Thromb Haemost 1997; 78(01): 571-576
DOI: 10.1055/s-0038-1657591
New treatments of von Wiltebrand disease
Schattauer GmbH Stuttgart

Recombinant von Willebrand Factor

Hans Peter Schwarz
1   Immuno AG, Vienna, Austria
,
Peter L Turecek
1   Immuno AG, Vienna, Austria
,
Ludwig Pichler
1   Immuno AG, Vienna, Austria
,
Artur Mitterer
1   Immuno AG, Vienna, Austria
,
Wolfgang Mundt
1   Immuno AG, Vienna, Austria
,
Friedrich Dorner
1   Immuno AG, Vienna, Austria
,
Jacqueline Roussi
2   Hôpital Raymond-Pointcaré, Garches
,
Ludovic Drouet
3   Hôpital Lariboisière, Paris, France
› Author Affiliations
Further Information

Publication History

Publication Date:
12 July 2018 (online)